Past Papers · SAQ
Sedatives — Midazolam
2022B Q01
Exam questionDescribe the pharmacology of midazolam.
CICMWrecks answer
Master answer
Midazolam
Core pharmacology
- Chemical Pharmaceutics
- Imidazole ring in its structure - Accounts for water solubility And rapid metabolism
- 2-3x potent Diazepam- Presentation
Clear solution pH 3.5 (IV/IM), Tablet
pKa 6.5 – 89% un-ionized- Mechanism of action
increases the sensitivity GABAA receptors which open (via GABA) and allow Cl influx
causing hyperpolarisation
- Influx of Cl- into nerve cell
- Hyperpolarised, preventing conduction- Physiological effects
CNS: Sedative, reduces epileptiform activity,
increases confusion and disorientation, amnesic properties more prominent than
sedative eff¬ects
CVS: minor hypotension has been reportedResp: respiratory depression - synergistic with opioids
- Absorption
A : IV,PO,In,IM
poor oral bioavailability 45%- Metabolism
hepatic via CYP3A4, and glucuronidation
active metabolite- Excretion
excreted in urine (as glucuronide conjugated metabolites)
- Half-life
half life 1-4 hrs
prolonged in cirrhosis, CRF, CCF, obesity, elderly- Route And Dose
2-2.5mg initially then 1mg boluses to eff¬ect
- Introduction
- Benzodiazepine
- Imidazole ring in its structure - Accounts for water solubility And rapid metabolism
- 2-3x potent Diazepam- Indications Uses
Sedative, amnesic+ anxiolytic,
antiepileptic- Distribution
lipid soluble at physiological pH (pKa 6.5).
high lipid sol crosses BBB- Class Group
Anticonvulsant Sedative-Hypnotic
- Volume of distribution
Volume of distribution approximately 0.8-1.5 L/kg, increasing to about 3.1 L/kg in critically ill patients.
- Protein binding
Approximately 96% protein-bound in plasma.
- Adverse Effects Toxicity
Respiratory depression and excessive sedation with overdosage
Same CYP as alfentanil (increases effect)
Past papers
Exam appearances
| Exam | Exact exam wording | Candidate success |
|---|---|---|
| 2022B Q01 | Describe the pharmacology of midazolam. | 88% |